Related Experiment Video
Updated: Oct 8, 2025
Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters
Published on: August 22, 2014
Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency
Indra Van Zundert1, Maria Bravo1, Olivier Deschaume2
1Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium.
Abstract:
The application of antibodies in nanomedicine is now standard practice in research since it represents an innovative approach to deliver chemotherapy agents selectively to tumors. The variety of targets or markers that are overexpressed in different types of cancers results in a high demand for antibody conjugated-nanoparticles, which are versatile and easily customizable. Considering up-scaling, the synthesis of antibody-conjugated nanoparticles should be simple and highly reproducible. Here, we developed a facile coating strategy to produce antibody-conjugated nanoparticles using 'click chemistry' and further evaluated their selectivity towards cancer cells expressing different markers. Our approach was consistently repeated for the conjugation of antibodies against CD44 and EGFR, which are prominent cancer cell markers. The functionalized particles presented excellent cell specificity towards CD44 and EGFR overexpressing cells, respectively. Our results indicated that the developed coating method is reproducible, versatile, and non-toxic, and can be used for particle functionalization with different antibodies. This grafting strategy can be applied to a wide range of nanoparticles and will contribute to the development of future targeted drug delivery systems.
Insights
Antibody-conjugated nanoparticles offer targeted cancer therapy. This study presents a simple, reproducible method using click chemistry for antibody conjugation, demonstrating high specificity for cancer cells and potential for advanced drug delivery systems.
Area of Science:
- Nanomedicine
- Bioconjugation Chemistry
- Cancer Therapeutics
Background:
- Antibodies are crucial for targeted chemotherapy delivery in nanomedicine.
- Antibody-conjugated nanoparticles offer versatile and customizable solutions for cancer treatment.
- Scalable, reproducible synthesis methods are needed for clinical translation.
Purpose of the Study:
- To develop a facile and reproducible coating strategy for antibody-conjugated nanoparticles.
- To evaluate the selectivity of antibody-conjugated nanoparticles against cancer cells expressing specific markers.
- To establish a versatile platform for nanoparticle functionalization in targeted drug delivery.
Main Methods:
- Utilized 'click chemistry' for a facile antibody conjugation strategy.
- Developed antibody-conjugated nanoparticles targeting CD44 and Epidermal Growth Factor Receptor (EGFR).
- Assessed nanoparticle selectivity towards cancer cells overexpressing CD44 and EGFR.
Main Results:
- The developed coating strategy demonstrated high reproducibility and versatility.
- Functionalized nanoparticles exhibited excellent cell specificity for CD44 and EGFR overexpressing cells.
- The non-toxic coating method is suitable for various nanoparticle types and antibody conjugations.
Conclusions:
- The facile click chemistry-based coating strategy enables reproducible antibody conjugation to nanoparticles.
- This method provides highly specific targeting of cancer cells, paving the way for advanced drug delivery systems.
- The versatile and non-toxic approach supports the development of next-generation targeted nanotherapeutics.
More Related Videos
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
09:06Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
